Blog

Apr 12, 2017

Billionaire Jim Mellon invests in anti-ageing research firm

Posted by in categories: biotech/medical, information science, life extension

Billionaire investor Jim Mellon has joined the push to solve age-related diseases and bring rejuvenation biotechnology to the world.


Billionaire biotechnology investor Jim Mellon has unveiled an investment in an ambitious new venture which seeks to tackle ageing and age-related diseases.

Insilico Medicine is a big data analytics company which says its mission is to ‘extend healthy longevity’.

This is a ‘moonshot’ target in health which has seen investment from a number of ambitious research groups in the last few years.

Read more

Comments are closed.